ASG Eye Hospital, a super-speciality eye care chain backed by General Atlantic, Kedaara Capital and Sky Impact Capital, announced the launch of Ocular Oncology Services.
The highlight of the launch was an international masterclass on retinoblastoma management conducted by Professor. Dr. Sagoo is a globally recognised consultant ophthalmic surgeon at Moorfields Eye Hospital (UK), specialising in adult and paediatric eye tumours like retinoblastoma and ocular melanoma. He shared globally benchmarked treatment protocols and multidisciplinary strategies, reinforcing ASG’s commitment to research-driven subspecialty care.
Another distinguished panellist was Dr. Neiwete Lomi, Associate Professor at AIIMS, (New Delhi), an ocular oncology specialist known for his work in retinoblastoma, who shed light on the Indian clinical perspective, highlighting the unique challenges and treatment approaches in managing ocular tumours in the country.
Data shows that India carries one of the highest burdens of retinoblastoma, a common childhood eye cancer, contributing a significant share of the global burden and reporting roughly 1,500 new cases annually.
While dedicated care has historically been the domain of a handful of long-established institutions like ASG’s multi-city network aims to decentralise access, enabling earlier detection and reducing travel for families. The expansion will continue in a phased manner across Kolkata, Varanasi, Bhopal, Coimbatore, Bengaluru, Patna and Guwahati, creating a comprehensive, multi-city ocular oncology network. The programme will be supported by a clinical advisory framework with experts associated with AIIMS New Delhi and internationally renowned specialists from Moorfields Eye Hospital, London. Patients will benefit from globally benchmarked protocols, structured case review, and coordinated care pathways for complex ocular tumours, including multidisciplinary evaluation when required.
Dr. Ganesh, the Chief Research and Academics Officer, ASG Eye Hospital, said, “Our goal is simple: patients should not have to travel across the country for critical eye cancer care. With retinoblastoma cases increasing every year, we believe it is the right time to build a structured ocular oncology programme across multiple centres across India. We will bring specialised expertise closer to communities to enable timely, protocol-led treatment for patients who need it the most.”
